17th Feb 2022 12:05 pm |
RNS |
Akili Data: Enhanced Brain Activity in Kids w/ADHD |
15th Feb 2022 7:00 am |
RNS |
PRTC's Akili Files Registration Statement on S-4 |
10th Feb 2022 12:00 pm |
RNS |
PRTC to Present at Leerink Healthcare Conference |
4th Feb 2022 7:00 am |
RNS |
PDMR DEALING - PURCHASE OF SHARES |
31st Jan 2022 11:50 am |
RNS |
PRTC's Gelesis Launches Plenity Media Campaign |
26th Jan 2022 12:02 pm |
RNS |
PRTC’s Akili to Become Public & $162M Funding |
14th Jan 2022 7:00 am |
RNS |
PRTC's Gelesis to Debut on NYSE Today Ticker GLS |
7th Jan 2022 12:00 pm |
RNS |
PureTech to Present at JPM Healthcare Conference |
6th Jan 2022 7:00 am |
RNS |
LYT-100 Shows Improved AE Profile vs Pirfenidone |
5th Jan 2022 12:05 pm |
RNS |
Gelesis Adds to BOD & Declared Effective by SEC |
20th Dec 2021 7:00 am |
RNS |
PDMR DEALING - PURCHASE OF SHARES |
16th Dec 2021 7:00 am |
RNS |
PRTC Provides Recap Ahead of Catalyst-Rich 2022 |
8th Dec 2021 12:00 pm |
RNS |
PRTC Presents Data at ACNP Conference For LYT-300 |
7th Dec 2021 12:00 pm |
RNS |
PRTC's Lymphatic Platform Candidate Human Study |
1st Dec 2021 12:10 pm |
RNS |
PRTC: Gelesis' Plenity Now Broadly Available in US |
1st Dec 2021 7:00 am |
RNS |
Total Voting Rights |
18th Nov 2021 12:10 pm |
RNS |
PRTC's Gelesis Receives $30M Plenity Order from Ro |
16th Nov 2021 12:00 pm |
RNS |
PRTC Publishes Previous LYT-100 MAD Study Results |
15th Nov 2021 12:00 pm |
RNS |
PRTC Presents at Two Upcoming Investor Conferences |
12th Nov 2021 12:00 pm |
RNS |
PRTC Presents Immunooncology Ph 1/2 Trial at SITC |
11th Nov 2021 12:00 pm |
RNS |
FDA Grants PRTC's LYT-200 Orphan Drug Designation |
10th Nov 2021 7:00 am |
RNS |
PRTC Receives $100M from Founded Entity Shares |
9th Nov 2021 12:34 pm |
RNS |
KRTX and Zai Lab to Develop KarXT in Greater China |
9th Nov 2021 7:00 am |
RNS |
PRTC Presents at Jefferies Healthcare Conference |
1st Nov 2021 10:20 am |
RNS |
New Research in Journal Nature on Gelesis Tech |
1st Nov 2021 7:00 am |
RNS |
Total Voting Rights |
22nd Oct 2021 6:00 pm |
RNS |
Holdings in Company - TR-1 Correction Announcement |
20th Oct 2021 4:35 pm |
RNS |
Price Monitoring Extension |
14th Oct 2021 12:01 pm |
RNS |
PRTC's Vedanta Appoints Chief Legal Officer |
12th Oct 2021 7:00 am |
RNS |
Additional Listing |
5th Oct 2021 1:01 pm |
RNS |
Vedanta Positive Phase 2 Data in C. Diff Infection |
5th Oct 2021 1:00 pm |
RNS |
PRTC's Sonde Launches Mental Health Monitor |
29th Sep 2021 1:01 pm |
RNS |
Akili/Shionogi Report Positive Ph2 Data in Japan |
20th Sep 2021 4:02 pm |
RNS |
New PureTech Research Published In Nature Journal |
14th Sep 2021 12:00 pm |
RNS |
PRTC to Present at Oppenheimer Healthcare Summit |
1st Sep 2021 7:00 am |
RNS |
Total Voting Rights |
24th Aug 2021 7:00 am |
RNS |
Half-year Report |
23rd Aug 2021 12:00 pm |
RNS |
PRTC Presents LYT-100 Ph1 PK & Tolerability at ERS |
17th Aug 2021 1:03 pm |
RNS |
Akili Deal Furthers Digital Medicine Leadership |
13th Aug 2021 12:00 pm |
RNS |
PRTC Appoints Industry Veteran & Physician as CMO |